Related Experiment Videos

Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67

E Knosp1, K Kitz, A Perneczky

  • 1Department of Neurosurgery, University Medical School Vienna, Austria.

Neurosurgery
|December 1, 1989
PubMed

Insights

The monoclonal antibody (MAb) Ki-67 is a reliable tool for assessing pituitary adenoma growth rates. Invasive adenomas showed significantly higher proliferation activity than noninvasive ones.

Area of Science:

  • Oncology
  • Immunohistochemistry
  • Endocrinology

Background:

  • The monoclonal antibody (MAb) Ki-67 identifies a nuclear antigen present in proliferating cells throughout the cell cycle.
  • MAb Ki-67 offers a direct method for determining tumor growth rates using frozen sections or cytological smears, unlike traditional histological methods.

Purpose of the Study:

  • To investigate the proliferation activity of pituitary adenomas using the MAb Ki-67.
  • To correlate proliferation activity with the hormonal status and invasiveness of pituitary adenomas.

Main Methods:

  • Sixty-two pituitary adenomas were analyzed using the MAb Ki-67.
  • A two-step avidin-biotin-peroxidase complex technique was employed for immunohistochemical staining.

Main Results:

  • Proliferation activity in the studied pituitary adenomas ranged from 0.1% to 2.8%.
  • No significant correlation was found between proliferation activity and the hormonal state of the adenomas.
  • Pituitary adenomas with histological evidence of dural infiltration exhibited significantly higher proliferation activity (P < 0.05) compared to noninvasive adenomas.

Conclusions:

  • MAb Ki-67 is a valuable marker for assessing pituitary adenoma proliferation.
  • Tumor invasiveness, specifically dural infiltration, is associated with increased cellular proliferation in pituitary adenomas.

Related Concept Videos